A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.

M. Fukuoka, H Niitani, Atsushi Suzuki, +7

Journal of Clinical Oncology

Phase I Study of Weekly Intravenous Infusions of CPT-11, a New Derivative of Camptothecin, in the Treatment of Advanced Non-Small-Cell Lung Cancer

S. Negoro, M. Fukuoka, N Masuda, +7

JNCI Journal of the National Cancer Institute

[Phase II study].

H Niitani

PubMed

OncologyPreclinical Drug EvaluationMedicineNew Anti-tumor DrugsPharmacotherapy +9

Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study.

Hideo Kunitoh, Kyohei Watanabe, T Onoshi, +3

Journal of Clinical Oncology

Phase II Study of Vinorelbine in Heavily Previously Treated Small Cell Lung Cancer

Kiyoyuki Furuse, Kaoru Kubota, Masaaki Kawahara, +9

Oncology

[Phase I clinical trial of RP 56976 (docetaxel) a new anticancer drug].

Takao Taguchi, H Furue, H Niitani, +7

PubMed

Therapeutic Drug MonitoringOncologyRp 56976Metronomic TherapyPharmacology +11

The quality of life questionnaire for cancer patients treated with anticancer drugs (QOL-ACD): Validity and reliability in Japanese patients with advanced non-small-cell lung cancer

T Matsumoto, Yasuo Ohashi, Satoshi Morita, +8

Quality of Life Research

Induction of intercellular adhesion molecule 1 on small cell lung carcinoma cell lines by gamma-interferon enhances spontaneous and bispecific anti-CD3 x antitumor antibody-directed lymphokine activated killer cell cytotoxicity.

Arata Azuma, Hideo Yagita∥, Hiroshi Matsuda, +2

PubMed

Tumor ImmunologySignal TransductionAnti-sclc MabNatural LigandCancer Immunosurveillance +13

Randomized study of vinorelbine (VRB) versus vindesine (VDS) in previously untreated stage IIIB or IV non-small-cell lung cancer (NSCLC)

Kiyoyuki Furuse, M. Fukuoka, Mutsuo Kuba, +10

Annals of Oncology

MedicineBronchial NeoplasmUntreated Stage IiibVersus VindesineCancer Treatment +6

myc Family gene abnormality in lung cancers and its relation to xenotransplantability

A Gemma, T Nakajima, Mie Shiraishi, +4

Lung Cancer

Lung CancersSomatic VariantOncogenic AgentGeneticsPathology +6